Table 1. Correlations among NSCLC genomic markers and PD-L1. Wilcoxon rank-sum test was used for generating the P-values.
| P-value | q-Value* | PD-L1(TPS+) | |
|---|---|---|---|
| EGFR/PD-L1 | 0.0025 | 0.01 | continuous |
| 0.0137 | 0.05 | 5% | |
| 0.002 | 0.009 | 20% | |
| 0.0003 | 0.001 | 50% | |
| MET/PD-L1 | 0.004 | 0.01 | continuous |
| 0.01 | 0.05 | 5% | |
| 0.0006 | 0.001 | 20% | |
| 0.01 | 0.05 | 50% | |
| TP53/PD-L1 | <0.0001 | <0.0001 | continuous |
| 0.0004 | 0.001 | 5% | |
| 0.0003 | 0.001 | 20% | |
| 0.007 | 0.01 | 50% | |
| KRAS+TP53/PD-L1 | 0.0002 | 0.0008 | continuous |
| 0.001 | 0.01 | 5% | |
| 0.0002 | 0.001 | 50% | |
| EGFR/TP53 | 0.0002 | 0.001 | N/A |
| KRAS/PD-L1 | No Correlation | ||
*P-value after adjusting for multiple testing.
+Tumor proportion score.